Call for Abstracts Open: 19 July 2019
Call for Abstracts close: 2 December 2019
Registration Open: 25 October 2019
Abstract Author Notification: 28 January 2020
Early Bird and Author Registration Deadline: 7 February 2020
Express Your Interest
Join our mailing list to be kept up to date
with information on the Meeting.
The NDLR meeting is proudly supported by the Leukaemia Foundation.
The Scientific and Organising Committees invite you to participate in the 8th New Directions in Leukaemia Research (NDLR) meeting to be held at the Brisbane Convention and Exhibition Centre in Queensland, Australia, from Monday 23 March to Wednesday 25 March, 2020.
The goal of the NDLR conferences is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia to new therapies emerging in the clinic.
As one of the premier international leukaemia conferences, NDLR 2020 will again bring together early-career investigators and senior scientists. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, allowing new collaborations to be forged.
Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR conferences offer a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.
We look forward to seeing you at NDLR 2020.
Associate Professors Matthew McCormack & Ross Dickins (co-chairs)
NDLR 2018 Delegates